The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 11,901–12,000 of 31,469
Elbaset, M. A., Nasr, M., Ibrahim, B. M. M., Ahmed-Farid, O. A.-H., Bakeer, R. M., Hassan, N. S., & Ahmed, R. F. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14442 · Cited by 32
Li, L., Yao, H., Dai, W., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.988257 · Cited by 29
Neves, J. S., Fontes‐Carvalho, R., Borges‐Canha, M., Leite, A. R., von Hafe, M., Vale, C., Martins, S., Guimarães, J. T., Carvalho, D. M., Leite-Moreira, A. F., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1067801 · Cited by 30
Hao, S., Ming, L., Li, Y., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1072133 · Cited by 29
Zhu, J., Han, J., Liu, L., Liu, Y., Xu, W., Li, X., Yang, L., Gu, Y., Tang, W., Shi, Y., et al. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110568 · Cited by 31
Relationship Between Cardiometabolic Index and Insulin Resistance in Patients with Type 2 Diabetes
Wu, L., & Xu, J. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s449374 · Cited by 29
Kim, M., & Bae, Y. (2015) · Clinical Nutrition Research · doi:10.7762/cnr.2015.4.3.175 · Cited by 29
Jiménez‐Pavón, D., Ruiz, J. R., Ortega, F. B., Martínez‐Gómez, D., Moreno, S., Urzanqui, A., Gottrand, F., Molnár, D., Castillo, M. J., Sjöstróm, M., et al. (2013) · Pediatric Diabetes · doi:10.1111/pedi.12000 · Cited by 31
Favor, J. D. L., Anderson, E. J., Hickner, R. C., & Wingard, C. J. (2012) · The Journal of Sexual Medicine · doi:10.1111/jsm.12001 · Cited by 29
Buttacavoli, M., Gruttad’Auria, C. I., Olivo, M., Virdone, R., Castrogiovanni, A., Mazzuca, E., Marotta, A. M., Marrone, O., Madonia, S., & Bonsignore, M. R. (2015) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2015.08.009 · Cited by 29
Beltrán‐Debón, R., Rodríguez‐Gallego, E., Fernández‐Arroyo, S., Senan, O., Massucci, F. A., Hernández‐Aguilera, A., Sales‐Pardo, M., Guimerà, R., Camps, J., Menéndez, J. A., et al. (2015) · Food & Function · doi:10.1039/c5fo00696a · Cited by 29
Isocaloric intake of a high‐fat diet promotes insulin resistance and inflammation in Wistar rats
Jacob, P., Fujii, T. M. D. M., Yamada, M., Borges, M. C., Pantaleão, L. C., Borelli, P., Fock, R. A., & Rogero, M. M. (2012) · Cell Biochemistry and Function · doi:10.1002/cbf.2894 · Cited by 30
Insulin Resistance in Nondiabetic Peritoneal Dialysis Patients
Bernardo, A. P., Oliveira, J. C., Santos, O., et al. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03170315 · Cited by 29
Green, C. A., Yarborough, B. J. H., Leo, M. C., Stumbo, S. P., Perrin, N., Nichols, G. A., & Stevens, V. J. (2015) · Obesity · doi:10.1002/oby.21205 · Cited by 30
Haugaard, S. B., Andersen, O., Hansen, T. W., Eugen‐Olsen, J., Linneberg, A. R., Madsbad, S., Olsen, M. H., Jørgensen, T., Borch‐Johnsen, K., & Jeppesen, J. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03513.x · Cited by 28
Association between nocturnal blood pressure dipping and insulin metabolism in obese adolescents
Westerståhl, M., & Marcus, C. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.181 · Cited by 29
Katulanda, P., Shine, B. S. F., Katulanda, G. W., Silva, A. P., Asfir, E. L., Sheriff, R., Somasundaram, N. P., Long, A. E., Bingley, P. J., McCarthy, M. I., et al. (2008) · Diabetologia · doi:10.1007/s00125-008-1052-6 · Cited by 29
Self-citationAdiponectin, Leptin and Ghrelin Levels in Obese Adolescent Girls with Polycystic Ovary Syndrome
GÜRBÜZ, T., Akhan, S. E., Baştu, E., Telci, A., İyibozkurt, A. C., & Topuz, S. (2012) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2012.09.002 · Cited by 29
Olafsdottir, E., Aspelund, T., Sigurdsson, G. T., Þórsson, B., Benediktsson, R., Harris, T. B., Launer, L. J., Eiríksdóttir, G., & Gudnason, V. G. (2009) · European Journal of Epidemiology · doi:10.1007/s10654-009-9343-x · Cited by 29
Davis, D. A., Pellowski, D. M., Davis, D. A., & Donahoo, W. T. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803120 · Cited by 29
Marcondes, J. A. M., Yamashita, S. A. Y., Maciel, G. A. R., Baracat, E. C., & Halpern, A. (2007) · Gynecological Endocrinology · doi:10.1080/09513590701192529 · Cited by 29
Catalano, D., Trovato, G. M., Spadaro, D., Martines, G. F., Garufi, G., Tonzuso, A., Grasso, D., & Sciacchitano, S. (2008) · Climacteric · doi:10.1080/13697130802348728 · Cited by 29
Weiler, H. A., Lowe, J., Krahn, J., & Leslie, W. D. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.12.007 · Cited by 29
Anti-Diabetic Effect of Pectinase-Processed Ginseng Radix (GINST) in High Fat Diet-Fed ICR Mice
Yuan, H. D., Quan, H. Y., Jung, M. S., Kim, S., Huang, B., Kim, D., & Chung, S.-H. (2011) · Journal of Ginseng Research · doi:10.5142/jgr.2011.35.3.308 · Cited by 28
Hopkins, M., Gibbons, C., Caudwell, P., Webb, D., Hellström, P. M., Näslund, E. B., Blundell, J. E., & Finlayson, G. (2014) · International Journal of Endocrinology · doi:10.1155/2014/323728 · Cited by 31
Oat beta-glucan ameliorates insulin resistance in mice fed on high-fat and high-fructose diet
Zheng, J., Shen, N., Wang, S., & Zhao, G. (2013) · Food & Nutrition Research · doi:10.3402/fnr.v57i0.22754 · Cited by 29
Depressive Symptoms, Antidepressant Medication Use, and Insulin Resistance
Pyykkönen, A.-J., Räikkönen, K., Tuomilehto, J., Eriksson, J. G., Groop, L., & Isomaa, B. (2011) · Diabetes Care · doi:10.2337/dc11-0107 · Cited by 29
Brunner, S., Schmid, D., Hüttinger, K., Much, D., Heimberg, E., Sedlmeier, E. ‐., Brüderl, M., Kratzsch, J., Bader, B., Amann‐Gassner, U., et al. (2013) · Diabetic Medicine · doi:10.1111/dme.12298 · Cited by 29
Perlstein, T. S., Henry, R. R., Mather, K. J., Rickels, M. R., Abate, N. I., Grundy, S. M., Mai, Y., Albu, J., Marks, J. B., Pool, J. L., et al. (2011) · Clinical Science · doi:10.1042/cs20110284 · Cited by 30
Adult glucose metabolism in extremely birthweight-discordant monozygotic twins
Frost, M., Petersen, I., Brixen, K., Beck‐Nielsen, H., Holst, J. J., Christiansen, L., Højlund, K., & Christensen, K. (2012) · Diabetologia · doi:10.1007/s00125-012-2695-x · Cited by 29
Impaired glucose tolerance and type 2 diabetes mellitus: a new field for pediatrics in Europe
Wiegand, S., Dannemann, A., Krude, H., & Grüters, A. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803081 · Cited by 29
Can serum gamma-glutamyltransferase levels be useful at diagnosing gestational diabetes mellitus?
Alanbay, İ., Çoksüer, H., Ercan, C. M., Keskin, U., Karaşahin, E., Öztürk, M., Tapan, S., Öztürk, Ö., Kurt, İ., & Ergün, A. (2012) · Gynecological Endocrinology · doi:10.3109/09513590.2011.588756 · Cited by 29
Metabolic syndrome: A review of emerging markers and management
Singh, B. K., Arora, S., Goswami, B., & Mallika, V. (2009) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2009.04.012 · Cited by 29
Liraglutide prevents diabetes progression in prediabetic OLETF rats
Guo, N., Sun, J. M., Chen, H., Zhang, H., Zhang, Z., & Cai, D.-H. (2012) · Endocrine Journal · doi:10.1507/endocrj.ej12-0094 · Cited by 29
Møller, N. C., Grøntved, A., Wedderkopp, N., Ried‐Larsen, M., Kristensen, P. L., Andersen, L. B., & Froberg, K. (2010) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00316.2010 · Cited by 31
Cabrera‐Rode, E., Molina, G., Arranz, C., Vera, M., González, P., Suárez, R., Prieto, M., Padron, S. A., León, R., Tillán, J., et al. (2006) · Autoimmunity · doi:10.1080/08916930600738383 · Cited by 29
Ryoo, J., & Park, S. K. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.11.024 · Cited by 29
Nishimura, M., Tsukamoto, K., Tamaki, N., Kikuchi, K., Iwamoto, N., & Ono, T. (2010) · Kidney International · doi:10.1038/ki.2010.392 · Cited by 29
Yu, H., Li, S., Cao, M., Jiang, X., Feng, L., Zhao, J., & Gao, L. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.12 · Cited by 29
Belo, L., Nascimento, H., Kohlová, M., Bronze-da-Rocha, E., Fernandes, J. C., Costa, E. M., Catarino, C., Aires, L., Mansilha, H. F., Rocha‐Pereira, P., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098467 · Cited by 29
Metabolic syndrome, endothelial function and lifestyle modification
Aizawa, K., Shoemaker, J. K., Overend, T. J., & Petrella, R. J. (2009) · Diabetes and Vascular Disease Research · doi:10.1177/1479164109336375 · Cited by 29
Karadeniz, M., Erdoğan, M., Zengi, A., Eroğlu, Z., Tamsel, S., Olukman, M., Saygılı, F., & Yılmaz, C. (2010) · Endocrine · doi:10.1007/s12020-010-9370-0 · Cited by 29
Seufert, J., & Urquhart, R. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.11.014 · Cited by 31
Gianturco, V., Troisi, G., Bellomo, A., Bernardini, S., D’Ottavio, E., Formosa, V., Iacono, C. L., Verrusio, W., Marigliano, B., & Marigliano, V. (2012) · Hepatology International · doi:10.1007/s12072-012-9387-y · Cited by 30
Nagata, Y., Goto, H., HIKIAMI, H., Nogami, T., Fujimoto, M., Shibahara, N., & Shimada, Y. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/359282 · Cited by 29
Follow up of intima–media thickness after severe early‐onset preeclampsia
Blaauw, J., Souwer, E. T. D., Coffeng, S. M., Smit, A. J., van Doormaal, J. J., Faas, M. M., & van Pampus, M. G. (2014) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.12499 · Cited by 30
Metformin treatment improves weight and dyslipidemia in children with metabolic syndrome
Luong, D. Q., Oster, R. A., & Ashraf, A. P. (2014) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2014-0201 · Cited by 29
Insulin clearance: confirmation as a highly heritable trait, and genome-wide linkage analysis
Guo, X., Cui, J., Jones, M. R., Haritunians, T., Xiang, A. H., Chen, Y. I., Taylor, K. D., Buchanan, T. A., Davis, R. C., Hsueh, W. A., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2577-2 · Cited by 29
Changes in 24-h substrate oxidation in older and younger men in response to exercise
Melanson, E. L., Donahoo, W. T., Grunwald, G. K., & Schwartz, R. S. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01455.2006 · Cited by 29
Huang, G., Wang, X., Zhang-wei, L., Li, H., Li, X., & Zhou, Z. (2010) · Acta Diabetologica · doi:10.1007/s00592-010-0196-2 · Cited by 29
Kawasaki, T., Ohta, M., Kawano, Y., Masuda, T., Gotoh, K., Inomata, M., & Kitano, S. (2015) · Surgery Today · doi:10.1007/s00595-015-1135-1 · Cited by 29
Fitness and Adiposity Are Independently Associated with Cardiometabolic Risk in Youth
Buchan, D. S., Young, J. D., Boddy, L. M., Malina, R. M., & Baker, J. S. (2013) · BioMed Research International · doi:10.1155/2013/261698 · Cited by 29
Anan, F., Masaki, T., Shimomura, T., Fujiki, M., Umeno, Y., Eshima, N., Saikawa, T., & Yoshimatsu, H. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.08.021 · Cited by 29
Morning cortisol is lower in obese individuals with normal glucose tolerance
Ammini, A., Sahoo, Kulshreshtha, Khurana, Gupta, M., Dwivedi, Kumar, V., & Ammini, A. (2011) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s23915 · Cited by 29
Nonalcoholic fatty liver disease (NAFLD) without insulin resistance: Is it different?
Singh, S. P., Misra, B., Kar, S. K., Panigrahi, M. K., Misra, D., Bhuyan, P., Pattnaik, K., Meher, C., Agrawal, O., Rout, N., et al. (2014) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2014.08.014 · Cited by 29
Determinants of plasma apolipoprotein A‐V and APOA5 gene transcripts in humans
Hahne, P., Krempler, F., Schaap, F. G., Soyal, S. M., Höffinger, H., Miller, K., Oberkofler, H., Strobl, W., & Patsch, W. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.01987.x · Cited by 30
Effect of Telmisartan on Forearm Postischemic Hyperemia and Serum Asymmetric Dimethylarginine Levels
Tomiyama, H., Yamada, J., Koji, Y., Shiina, K., Yoshida, M., & Yamashina, A. (2007) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2007.07.013 · Cited by 29
Giordano, N., Tikhonoff, V., Palatini, P., Bascelli, A., Boschetti, G., Lazzari, F. D., Grasselli, C., Martini, B., Caffi, S., Piccoli, A., et al. (2012) · International Journal of Hypertension · doi:10.1155/2012/274851 · Cited by 29
Elion, R., DeJesus, E., Sension, M., et al. (2008) · HIV Clinical Trials · doi:10.1310/hct0903-152 · Cited by 29
Michaud, A., Lacroix‐Pepin, N., Pelletier, M., Veilleux, A., Noël, S., Bouchard, C., Marceau, P., Fortier, M. A., & Tchernof, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090861 · Cited by 29
Genelhu, V. A., Celoria, B. M. J., Duarte, S. F. P., Cabello, P. H., & Francischetti, E. A. (2008) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2008.09.009 · Cited by 32
Jamurtas, A. Z., Garyfallopoulou, A., Theodorou, A. A., Zalavras, A., Paschalis, V., Deli, C. K., Nikolaidis, M. G., Fatouros, I. G., & Koutedakis, Y. (2013) · European Journal of Applied Physiology · doi:10.1007/s00421-013-2717-5 · Cited by 28
Delisle, H. F., Ntandou, G., Sodjinou, R., Couillard, C., & Després, J. (2013) · Nutrients · doi:10.3390/nu5041366 · Cited by 29
Pontiroli, A. E., Pizzocri, P., Caumo, A., Perseghin, G., & Luzi, L. (2004) · Acta Diabetologica · doi:10.1007/s00592-004-0147-x · Cited by 29
Olza, J., Mesa, M. D., Aguilera, C. M., Moreno‐Torres, R., Jimenez, A. A., de la Cruz, A. P., & Gil, Á. (2009) · Clinical Nutrition · doi:10.1016/j.clnu.2009.06.003 · Cited by 29
Rhee, S. Y., Chon, S., Oh, S., Kim, S. W., Kim, J., Kim, Y. S., & Woo, J. (2006) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.09.035 · Cited by 29
de Luis, D. A., Aller, R., Izaola, O., Sagrado, M. G., & Conde, R. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.07.005 · Cited by 30
Influence of age on the relation between waist circumference and cardiometabolic risk markers
Janssen, I. (2008) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2008.06.013 · Cited by 30
Intolerancia a la glucosa en niños y adolescentes obesos
Yeste, D., Betancourth, S., Gussinyé, M., Potau, N., & Carrascosa, A. (2005) · Medicina Clínica · doi:10.1157/13079381 · Cited by 29
Fernández‐Real, J. M., Ortega, F. J., Gómez‐Ambrosi, J., Salvador, J., Frühbeck, G., & Ricart, W. (2010) · Osteoporosis International · doi:10.1007/s00198-010-1174-9 · Cited by 30
Jiao, K., Liu, H., Chen, J., Tian, D., Hou, J., & Kaye, A. D. (2008) · Cytokine · doi:10.1016/j.cyto.2007.12.002 · Cited by 29
Celık, T., Yüksel, U. Ç., Fıcı, F., et al. (2012) · Blood Pressure · doi:10.3109/08037051.2012.716580 · Cited by 29
Lourenço, B. H., Arthur, T., Rodrigues, M. D. B., Guazzelli, I. C., Frazzatto, E., Deram, S., Nicolau, C. Y., Halpern, A., & Villares, S. M. (2007) · Appetite · doi:10.1016/j.appet.2007.07.004 · Cited by 30
Garcia-Diaz, D., Campión, J., Milagro, F., Paternain, L., Solomon, A., & Martínez, J. A. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2008.01942.x · Cited by 31
Relationships of Hair Mineral Concentrations with Insulin Resistance in Metabolic Syndrome
Choi, W.-S., Kim, S., & Chung, J. (2014) · Biological Trace Element Research · doi:10.1007/s12011-014-9946-2 · Cited by 29
Juárez-Rojas, J. G., Medina-Urrutia, A. X., Galarza, E. J., Caracas-Portilla, N., Posadas‐Sánchez, R., Cardoso-Saldaña, G. C., Goycochea-Robles, M., Silveira, L., Lino-Pérez, L., Mas‐Oliva, J., et al. (2011) · Lupus · doi:10.1177/0961203311422096 · Cited by 29
Yakub, M., Schulze, K. J., Khatry, S. K., et al. (2014) · Nutrients · doi:10.3390/nu6041649 · Cited by 29
Transgenerational metabolic outcomes associated with uteroplacental insufficiency
Tran, M., Gallo, L. A., Jefferies, A. J., Moritz, K. M., & Wlodek, M. E. (2013) · Journal of Endocrinology · doi:10.1530/joe-12-0560 · Cited by 30
Malhotra, J. D., Tonorezos, E. S., Rozenberg, M., Vega, G. L., Sklar, C. A., Chou, J. F., Moskowitz, C. S., Eshelman‐Kent, D. A., Janiszewski, P. M., Ross, R., et al. (2012) · Journal of Lipid Research · doi:10.1194/jlr.p029785 · Cited by 29
Daoussis, D., Panoulas, V. F., Toms, T. E., et al. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2775 · Cited by 29
Erythrocyte Hyperaggregation in Obesity: Determining Factors and Weight Loss Influence
Solá, E., Vayá, A., Corella, D., et al. (2007) · Obesity · doi:10.1038/oby.2007.253 · Cited by 29
Long-term effects of a protein-enriched diet on blood pressure in older women
Hodgson, J. M., Zhu, K., Lewis, J. R., Kerr, D. A., Meng, X., Solah, V. A., Devine, A., Binns, C. W., Woodman, R. J., & Prince, R. L. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114511004740 · Cited by 29
Endothelial dysfunction and non-alcoholic liver steatosis in hypertensive patients
Sciacqua, A., Perticone, M., Miceli, S., Laino, I., Tassone, E. J., Grembiale, R. D., Andreozzi, F., Sesti, G., & Perticone, F. (2010) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.11.015 · Cited by 29
Lim, S. K., Kim, J. H., Yoon, J. W., Kang, S. M., Choi, S. H., Park, Y. J., Kim, K. W., Cho, N. H., Shin, H., Park, K. S., et al. (2011) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2011.07.013 · Cited by 29
Sumida, Y., Yonei, Y., Kanemasa, K., Hara, T., Inada, Y., Sakai, K., Imai, S., Hibino, S., Yamaguchi, K., Mitsuyoshi, H., et al. (2010) · Hepatology Research · doi:10.1111/j.1872-034x.2010.00704.x · Cited by 29
Chang, Y., Chang, L., Chang, T., Jiang, Y., Lee, K., Kuo, S., Lee, W., & Chuang, L. (2009) · Obesity · doi:10.1038/oby.2009.198 · Cited by 29
Subclinical Atherosclerosis and Obesity Phenotypes Among Mexican Americans
Laing, S. T., Smulevitz, B., Vatcheva, K. P., Rahbar, M. H., Reininger, B. M., McPherson, D. D., McCormick, J. B., & Fisher‐Hoch, S. P. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.114.001540 · Cited by 29
Rusu, E., Jinga, M., Enache, G., Rusu, F., Dragomir, A., Ancuta, I., Dragut, R., Parpala, C., Nan, R., Sima, I. I., et al. (2013) · Nutrition Journal · doi:10.1186/1475-2891-12-119 · Cited by 31
Nicklas, T. A., O’Neil, C. E., & Fulgoni, V. L. I. (2014) · Journal of Nutrition · doi:10.3945/jn.114.194068 · Cited by 30
Fysekidis, M., Cosson, E., Banu, I., Duteil, R., Cyrille, C., & Valensi, P. E. (2014) · Metabolism · doi:10.1016/j.metabol.2014.09.006 · Cited by 29
Aye, M. M., Kilpatrick, E. S., Aburima, A. A., Wraith, K. S., Magwenzi, S., Spurgeon, B. E. J., Rigby, A. S., Sandeman, D. D., Naseem, K. M., & Atkin, S. L. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.113.000706 · Cited by 29
Estradiol In Vivo Induces Changes in Cardiomyocytes Size in Obese Rats
Obradovic, M. M., Sudar-Milovanovic, E. M., Zafirovic, S. S., Stanimirović, J., Labudović‐Borović, M., & Isenović, E. R. (2013) · Angiology · doi:10.1177/0003319713514477 · Cited by 28
Anan, F., Masaki, T., Ito, Y., Eto, T., Umeno, Y., Eshima, N., Saikawa, T., & Yoshimatsu, H. (2010) · Metabolism: Clinical and Experimental · doi:10.1016/j.metabol.2009.06.001 · Cited by 29
Chu, C.-H., Lee, J., Wang, M.-C., Lu, C.-C., Sun, C.-C., Chuang, M.-J., & Lam, H. (2008) · Metabolism · doi:10.1016/j.metabol.2008.05.006 · Cited by 29
Nonalcoholic fatty liver disease in severely obese individuals: The influence of bariatric surgery
de Andrade, A. R. C. F., Cotrim, H. P., Alves, E. S., Soares, D. A., Rocha, R., Almeida, A. D. M., Almeida, C. G., & de Freitas, L. A. (2008) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31838-1 · Cited by 29
Juárez-Rojas, J. G., Medina-Urrutia, A. X., Posadas‐Sánchez, R., Galarza, E. J., Mendoza-Peŕez, E., Caracas-Portilla, N., Cardoso-Saldaña, G. C., Muñoz-Gallegos, G., & Posadas‐Romero, C. (2008) · Lupus · doi:10.1177/0961203308093072 · Cited by 29
Adolescents with Mild Stunting Show Alterations in Glucose and Insulin Metabolism
Santos, C. D. D. L., Clemente, A. P. G., Martins, V. J. B., et al. (2010) · Journal of Nutrition and Metabolism · doi:10.1155/2010/943070 · Cited by 29
Patterns of insulin resistance in the general population of southeast Spain
Rojo‐Martínez, G., Esteva, I., de Adana, S. R., Catalá, M., Merelo, M. J., Tinahones, F. J., Gómez‐Zumaquero, J. M., Cuesta, A. L., Cardona, F., & Soriguer, F. (2004) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2004.01.004 · Cited by 29
Yılmaz, M. İ., Sönmez, A., Sağlam, M., et al. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq159 · Cited by 29
Shaikh, M. G., Grundy, R. G., & Kirk, J. M. W. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0533 · Cited by 29
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
